Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

SHP099

Copy Product Info
🥰Excellent
Catalog No. T3564Cas No. 1801747-42-1
Alias SHP099 free base, SHP-099, SHP 099

SHP099 (SHP099 free base) free base is an effective, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 =0.07 μM and p-ERK modulation in cells IC50 = 0.250 μM). SHP099 shows dose-dependent pathway inhibition and antitumor activity in xenograft models.

SHP099

SHP099

Copy Product Info
🥰Excellent
Purity: 99.4%
Catalog No. T3564Alias SHP099 free base, SHP-099, SHP 099Cas No. 1801747-42-1
SHP099 (SHP099 free base) free base is an effective, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 =0.07 μM and p-ERK modulation in cells IC50 = 0.250 μM). SHP099 shows dose-dependent pathway inhibition and antitumor activity in xenograft models.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$31In StockIn Stock
2 mg$44In StockIn Stock
5 mg$72In StockIn Stock
10 mg$101In StockIn Stock
25 mg$177In StockIn Stock
50 mg$237In StockIn Stock
100 mg$431In StockIn Stock
1 mL x 10 mM (in DMSO)$55In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.4%
Appearance:Solid
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

SHP099 AI Summary
SHP099 exhibits bioactivity as an allosteric inhibitor of SHP2, including both wild type and E76A mutant forms, with IC50 values of 60.0 nM and 120.0 nM respectively. It shows significant antiproliferative activity against various human cancer cell lines, such as KYSE520, ASPC1, SW1990, BXPC-3, and MV4-11, with IC50 values ranging from 240.0 nM to 104800.0 nM. The compound also demonstrates antiviral activity against SARS-CoV-2, inhibiting virus-induced cytotoxicity in Caco-2 cells by 49.74% at 10 μM concentration after 48 hours. Additionally, SHP099 exhibits oral bioavailability in C57BL/6 mice at 5 mg/kg with a bioavailability percentage of 46.0% and high solubility exceeding 500,000.0 nM at pH 6.8. It also shows inhibition of HDAC6 and displays binding affinity to both wild type and mutant forms of SHP2, significantly inducing cell cycle arrest and enhancing antitumor immunity in mouse models. Overall, SHP099 presents as a promising multi-potent compound with potential applications in cancer therapy and antiviral treatment..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
SHP099 (SHP099 free base) free base is an effective, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 =0.07 μM and p-ERK modulation in cells IC50 = 0.250 μM). SHP099 shows dose-dependent pathway inhibition and antitumor activity in xenograft models.
Targets&IC50
SHP2:0.07 μM, pERK:0.250 μM, BXPC-3 cells:72.86 μM, SHP2 (E69K):0.416 μM, TF-1 cell:1.73 μM, 4T1 cells:119.3 μM, SHP2E76K:2.896 μM, ASPC1 cells:64.04 μM, SHP2 (D61Y):1.241 μM, BaF3 cells:19.86 μM, Capan-2 cells:15.67 μM, SHP2A72V:1.968 μM, MV-4-11 cells:0.32 μM
SynonymsSHP099 free base, SHP-099, SHP 099
Chemical Properties
Molecular Weight352.26
FormulaC16H19Cl2N5
Cas No.1801747-42-1
SmilesCC1(N)CCN(CC1)c1cnc(c(N)n1)-c1cccc(Cl)c1Cl
Relative Density.1.326 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 15.8 mg/mL (44.85 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.84 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.8388 mL14.1941 mL28.3881 mL141.9406 mL
5 mM0.5678 mL2.8388 mL5.6776 mL28.3881 mL
10 mM0.2839 mL1.4194 mL2.8388 mL14.1941 mL
20 mM0.1419 mL0.7097 mL1.4194 mL7.0970 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy SHP099 | purchase SHP099 | SHP099 cost | order SHP099 | SHP099 chemical structure | SHP099 formula | SHP099 molecular weight